Menninger v. PPD Development, L.P.

Court of Appeals for the First Circuit·Decided July 24, 2025·No. 23-2030·Published

Opinion

United States Court of Appeals For the First Circuit

No. 23-2030

LISA MENNINGER,

Plaintiff, Appellee,

v.

PPD DEVELOPMENT, L.P.,

Defendant, Appellant.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS

[Hon. Leo T. Sorokin, U.S. District Judge]

Before

Aframe and Kayatta,*

Circuit Judges.

Douglas Hallward-Driemeier, with whom John P. Bueker and Ropes & Gray LLP were on brief, for appellant.

Stephanie Schuster, Douglas W. Baruch, Jennifer M.

Wollenberg, and Morgan, Lewis & Bockius LLP on brief for National Association of Manufacturers, amicus curiae.

Patrick J. Hannon, with whom Hartley Michon Robb Hannon LLP was on brief, for appellee.

July 24, 2025

* Judge Selya heard oral argument in this case and participated in the initial semble thereafter. His death on February 22, 2025, ended his involvement in this case. The remaining two panelists issued this opinion pursuant to 28 U.S.C. § 46(d).

KAYATTA, Circuit Judge. Dr. Lisa Menninger was the Executive Director for Laboratory Operations at a clinical laboratory division of PPD Development, L.P. (PPD). Menninger claims that PPD discriminated and retaliated against her because of her social anxiety disorder, in violation of the Americans with Disabilities Act (ADA) and Massachusetts antidiscrimination law. A jury agreed and awarded Menninger more than twenty-four million dollars in damages. PPD then moved for judgment as a matter of law, a new trial, and remittitur, but the district court denied those motions. For the reasons detailed below, we affirm.

I.

A.

Because PPD challenges the sufficiency of the evidence supporting the jury's verdict, we recount the events in the light most favorable to Menninger, "drawing all factual inferences and resolving all credibility determinations in her favor." Dimanche v. Mass. Bay Transp. Auth., 893 F.3d 1, 4 n.2 (1st Cir. 2018); see also Franchina v. City of Providence, 881 F.3d 32, 38 (1st Cir. 2018) ("[O]ur recounting of the facts . . . defer[s] to the jury's discernible resolution of disputed factual issues." (quotation marks and citation omitted)).

B.

PPD is a clinical research organization. It assists pharmaceutical companies in testing new drugs, researching

vaccines, and organizing and analyzing data from clinical trials. One of its divisions, Global Central Labs, focuses on clinical laboratory testing. Menninger was its Executive Director for Laboratory Operations.

In 2017, its business stagnating, PPD's senior management decided to implement a plan focusing on client relationships. As part of that plan, PPD tasked its operational leads -- including Menninger -- with increasing their involvement in client pitches, bid defenses, and other engagements with clients.

When Menninger's supervisor, Hacene Mekerri, told her about the planned change in her duties, Menninger balked. She explained to Mekerri that public presentations in front of large crowds "ma[d]e [her] anxious." Mekerri "tried to reassure [her]" that she was capable of the public speaking he had in mind, and he suggested that they return to the discussion "after the holidays." On January 11, 2018, Menninger emailed Mekerri to continue the conversation. She informed him that she suffered from generalized anxiety disorder, social anxiety disorder, and panic attacks, which she treated with medication as needed. She also explained that increased client visits, social interactions, and presentations would be "difficult in light of [her] disability," and that she was "open to discussing whatever ideas" Mekerri had for her role.

PPD proposed that Menninger have her doctor recommend accommodations that might allow Menninger to perform her new duties. After consulting with an attorney and her doctor, she agreed.

On January 31, 2018, Menninger's psychiatrist, Dr. Marianna Kessimian, submitted a written accommodation request on Menninger's behalf. The request noted that Menninger could "tolerate" public speaking and social interaction "to the extent that they [were] necessary for her job." However, it cautioned that expanding Menninger's public-speaking and social-interaction responsibilities would "increase her anxiety and worsen her somatic symptoms," making it "substantially more difficult, if not impossible, for [Menninger] to perform her job." Kessimian suggested three possible accommodations: (1) minimizing social interaction or public speaking "to the extent possible"; (2) not changing Menninger's role to require more public speaking or social interactions; and (3) developing a "plan" for any necessary public speaking and social interactions, in consultation with Kessimian or another qualified healthcare provider, so as to "minimize [Menninger's] anxiety and somatic symptoms."

In response, Human Resources (HR) Associate Director Chad St. John asked Menninger for additional information from her physician regarding the specific duties Mekerri had raised that Menninger could not perform. St. John also prompted Mekerri to

send Menninger an email, on February 6, listing five broad categories of public-speaking and social tasks that Menninger would be expected to perform (specifying the frequency and number of attendees for some, but not all, of the tasks). Some of the listed activities were ones that Menninger performed "regularly without issue," whereas others -- like being physically present for client site visits -- marked a sharp departure from her previous role.

Menninger worked with Kessimian to request a second set of accommodations specifically tailored to Mekerri's emailed list. Kessimian's additional suggestions included providing a "surrogate or reader" to attend client meetings or make presentations on Menninger's behalf. Kessimian also said that Menninger was "able to build business relationship[s] in a more 'behind the scenes' fashion and would like [to] brainstorm other potential avenues where she [could] add value" in the business-development context. Kessimian submitted the request on February 14, 2018.

St. John responded by email to Menninger twelve days later, stating that PPD could accommodate Menninger's requests for a surrogate to present at internal meetings, as well as her request to reduce travel expectations. However, he indicated that PPD could not make any accommodations with regard to "Client Bid Defense," "Issue resolution calls," "HH/Client site meetings,"

"phone," "Technical Sales presentation internal and external," and "Lunch/dinner and social interactions" during customer visits.

Two days later, Menninger was scheduled to meet with St. John and Mekerri to discuss the accommodation requests. Before the meeting, St. John emailed Deborah Ballweg, HR Executive Director, and mentioned "delicately working [Menninger] out," explaining that he and Mekerri "[g]ave only slightly on two out of five items that her physician requested" as reasonable accommodations.

During the meeting with St. John and Mekerri, Menninger sought more information about the specific responsibilities for which PPD stated that no accommodations were possible, because -- as she put it in a follow-up email -- she thought there were "many tasks that could fall within those items that would not implicate [her] disability." However, PPD would not provide those details. Instead, PPD focused on "working [Menninger] out," with St. John asking Menninger to either transition to "a temporary consulting role" or take an "exit package."

Predictably, matters deteriorated from there. Menninger made clear that she did not want to leave PPD. St. John sent a memorandum to PPD's legal department seeking guidance in pursuing an "an exit strategy" with Menninger. St. John also sent the legal department a draft email stating that to provide Menninger with further information about her new public-facing responsibilities

Free access — add to your briefcase to read the full text and ask questions with AI

Menninger v. PPD Development, L.P., (1st Cir. 2025).

Menninger v. PPD Development, L.P. (Menninger v. PPD Development, L.P.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Pacific Mutual Life Insurance v. Haslip
499 U.S. 1 (Supreme Court, 1991)
Kolstad v. American Dental Assn.
527 U.S. 526 (Supreme Court, 1999)
Barnes v. Gorman
536 U.S. 181 (Supreme Court, 2002)
Unitherm Food Systems, Inc. v. Swift-Eckrich, Inc.
546 U.S. 394 (Supreme Court, 2006)
Correa v. Hospital San Francisco
69 F.3d 1184 (First Circuit, 1995)
Kvorjak v. Maine, State of
259 F.3d 48 (First Circuit, 2001)
Blockel v. J.C. Penney Company
337 F.3d 17 (First Circuit, 2003)
Richards v. Relentless, Inc.
341 F.3d 35 (First Circuit, 2003)
Connelly v. Hyundai Motor Co.
351 F.3d 535 (First Circuit, 2003)
Zachar v. Lee
363 F.3d 70 (First Circuit, 2004)
Flynn v. AK Peters, Ltd.
377 F.3d 13 (First Circuit, 2004)
United States v. Maldonado-Garcia
446 F.3d 227 (First Circuit, 2006)
Mulloy v. Acushnet Company
460 F.3d 141 (First Circuit, 2006)
Casillas-Diaz v. Palau
463 F.3d 77 (First Circuit, 2006)
Tobin v. Liberty Mutual Insurance
553 F.3d 121 (First Circuit, 2009)
Mendez-Matos v. Municipality of Guaynabo
557 F.3d 36 (First Circuit, 2009)
Costa-Urena v. Segarra
590 F.3d 18 (First Circuit, 2009)